Expanding efficacy while maintaining an acceptable therapeutic index
02 Sept 2026
ADC Cytotoxic Payload
- Why do some ADCs achieve significant efficacy with manageable toxicity while others fail despite targeting the same antigen?
- Which characteristics of target, antibody, linker, payload, and patient biology most strongly determine clinical success?
Industry Expert
